Increasing Clinical Studies Propel Growth Of In Vitro Lung Model Market Is Supporting Development Across The In-Vitro Lung Model Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Much Larger Will The In-Vitro Lung Model Market Become By 2030 Compared To 2026?

The in-vitro lung model market has experienced substantial expansion recently. It is forecast to rise from $0.54 billion in 2025 to $0.65 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 21.0%. Historically, this growth has been driven by factors such as the limitations of animal models in respiratory investigations, the long-standing use of two-dimensional lung cell cultures, heightened research activity in respiratory diseases, an increase in academic lung biology research, and the initial adoption of organoid-based research techniques.

The in-vitro lung model market is projected to experience significant growth over the coming years, with its size anticipated to reach $1.29 billion in 2030 at a compound annual growth rate (CAGR) of 18.6%. This expansion during the forecast period is driven by factors such as an increasing need for predictive preclinical lung models, a growing emphasis on reducing animal testing, the broadening of respiratory drug development pipelines, rising investments in advanced in-vitro research tools, and the demand for more physiologically relevant lung disease models. Prominent trends for the upcoming period include the increasing adoption of three-dimensional lung models in drug research, the expanding application of lung-on-a-chip platforms for disease modeling, a rising preference for human-relevant in-vitro lung testing systems, the wider use of in-vitro lung models in toxicology and safety studies, and greater integration of these models into preclinical research pipelines.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

What Influential Factors Are Boosting The In-Vitro Lung Model Market Demand?

The expansion of clinical studies is projected to drive the future growth of the in vitro lung model market. These studies are defined as research inquiries carried out to assess the safety, efficacy, and results of novel medical interventions, pharmaceuticals, or diagnostic instruments in human subjects. The volume of clinical studies is escalating because of evolving healthcare requirements, a heightened need for sophisticated medical therapies, and the ongoing search for inventive remedies for intricate health issues. The in vitro lung model sector facilitates clinical research by providing regulated environments that allow for pharmaceutical testing, assessment of toxicity, disease simulation, and examination of biological reactions specific to the lungs. As an illustration, data from ClinicalTrials.gov, a US-based clinical trial registry, indicated in January 2024 that a total of 477,230 clinical trials were registered worldwide by the close of 2023, which represents an increase from the 437,508 trials documented in 2022. Consequently, the expansion in clinical investigations is fueling the in vitro lung model market.

How Is The In-Vitro Lung Model Market Distributed Across Key Segments?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Which Trends Are Shaping The In-Vitro Lung Model Market Landscape?

Leading companies operating within the in vitro lung model market are prioritizing the development of advanced 3D respiratory tissue models to improve their physiological relevance, enhance predictive accuracy, and strengthen preclinical testing capabilities. A 3D respiratory tissue model represents a three-dimensional structure grown in a laboratory, made up of primary or specialized respiratory cells cultivated in conditions that allow them to mimic the architecture and function of human airway tissues, encompassing aspects such as mucus production, ciliary movement, and barrier integrity. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, unveiled EpiNasal, a 3D respiratory tissue model created from primary human nasal epithelial cells. This model replicates functional features of nasal epithelium, including goblet cells, active tight junctions, and beating cilia, providing researchers with a highly relevant platform for evaluating the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

Who Are The Firms Contributing To The In-Vitro Lung Model Market Ecosystem?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

Access The Complete In-Vitro Lung Model Market Report:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Regional Market Leads The In-Vitro Lung Model Market?

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access In-Vitro Lung Model Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

Browse Through More Reports Similar to the Global In-Vitro Lung Model Market 2026, By The Business Research Company

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Lung Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Pulmonary Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/pulmonary-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795